In late May–June 2026, SEBI released guidance strengthening oversight of companies with significant export operations, signalling tighter scrutiny of foreign-exchange flows, related-party pricing, and disclosure standards. For trading houses and export-oriented manufacturers, this means audits are moving beyond stock-exchange listing compliance into operational scrutiny: inter-company transfer pricing, FEMA reporting alignment, and supply-chain documentation.
Traders classified as SMEs or scheduled to scale toward the main board face particular attention. Understanding what SEBI now expects—and what your auditor will verify—protects your capital-access runway.
Market signals
SEBI issued guidance in June 2026 strengthening thematic inspection protocols for listed and pre-IPO export companies, focusing on foreign-exchange receipts, related-party transaction pricing, and disclosure completeness. Auditors are now cross-checking FEMA Form 15CB (remittance of export proceeds) against audited financial statements and trade documentation. Traders who have delayed FEMA alignment or kept export pricing opaque face detention of capital-raise approvals and potential non-compliance findings that stall IPO timelines or trigger RBI referral.
SEBI's thematic inspections now mandate contemporaneous transfer-pricing documentation for inter-company exports, especially where export subsidiaries or overseas group entities buy from Indian parents. Companies without Form 3CD (TP audit report under Income Tax Act Section 92) or equivalent commercial justification for pricing above 110% or below 90% of comparable open-market rates face audit qualification and mandatory remediation notices. The compliance cost is a ₹20,000–₹50,000 TP audit; the penalty for avoidance is withholding of board-migration approval.
Export traders must now reconcile FEMA remittance certificates (FC-TDS statements, Form 15CB) with GST Refund Claim forms (RFD-01 series), showing that foreign-exchange inflows match declared export-turnover in GST filings. Gaps—unmatched receipts or suspiciously timed refund claims—trigger RBI and GSTN cross-reporting. Missing or delayed reconciliation can delay working-capital credit approval by 60–90 days as lenders now request FEMA-GST audit certificates before disbursing facility renewals.
Traders and manufacturers with export exposure must align three audit trails by end of Q2 FY2026–27: FEMA remittance certificates, GST export-claim filing, and audited financial statements. SEBI's guidance (effective June 2026) now triggers cross-departmental checks with RBI, DGFT and GSTN before stock-exchange approvals or IPO clearances proceed. Vinayakam Consultants helps export-oriented SMEs and mid-caps map these three data streams, prepare supporting TP documentation, and restructure inter-company pricing to withstand SEBI scrutiny—critical before any capital-market access or group restructuring.
Your action checklist
- Finance & Compliance Owner: Pull your last three years of FEMA Form 15CB remittances and GST RFD-01 refund claims; reconcile total export receipts line-by-line and flag any unmatched amounts or timing gaps. Document the commercial reason for any variance >5%.
- Accountant: Commission a Form 3CD transfer-pricing study (Income Tax Section 92) for any inter-company export sale priced outside the 90–110% band relative to independent comparable transactions. File by September 30, 2026 to pre-empt audit qualification.
Frequently asked questions
SEBI strengthened oversight protocols for export companies, requiring tighter scrutiny of foreign-exchange flows, related-party transaction pricing, and disclosure completeness. Auditors now cross-check FEMA Form 15CB against financial statements and trade documentation.
Companies must maintain Form 3CD (TP audit report under Income Tax Section 92) and contemporaneous documentation justifying inter-company export pricing within 90–110% of comparable open-market rates, or face audit qualification and remediation notices.
Traders with delayed FEMA alignment or opaque export pricing face detention of capital-raise approvals and non-compliance findings that stall IPO timelines or trigger RBI referral, making alignment critical before pre-IPO audits.